BOYS MARK LAURENCE,DELISLE ROBERT KIRK,KENNEDY APRIL L,MEDINA MATTHEW DAVID,RAST BRYSON,RODRIGUEZ MARTHA E,ZHAO QIAN,BRADLEY MICHAEL F,HENNINGS D DAVID,MARMSATER FREDERIK P,MUNSON MARK C,RIZZI JAMES P
申请号：
ZA201205505
公开号：
ZA201205505B
申请日:
2012.07.20
申请国别(地区):
ZA
年份:
2013
代理人:
摘要：
Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4 and R5 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases and pain.
